image

The best stocks to buy since 1993

Latest issue now available

Luceco - Set to become a growth compounder

June 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • LUCE
  • Price:
  • 180p
SCSW’s Growth Portfolio 3 has had a scorcher of a month. In fact, it’s the third great month in a row, during which time the portfolio has gained 21.7%.  Even before this recent rally, a few subscribers who had recently joined asked me if I would start Growth Portfolio 4. Yes, I think that time is approaching but for now, I’m just hoping to continue with the present innings as momentum has returned with a vengeance to small caps. If GP3 gets to £600k, then I will seriously consider it. One of the holdings I would be buying had I been starting GP4 this month is Luceco, already held by GP3 and one of my New Year NAPS for the year. Inspecs (SPEC; 68.5p) would be a close contender but it’s a bit earlier in its recovery. For reg ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe